Clinical Trials Browser

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

Prostatic Neoplasms

Extensive Stage Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Squamous Cell Carcinoma of Head and Neck

Pancreatic Intraductal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck, Papillomavirus Infections

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Neuroblastoma, Ganglioneuroblastoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Precancerous Conditions, Papillomavirus Infections

Uterine Cervical Neoplasms

Carcinoma, Non-Small-Cell Lung

Rectal Neoplasms

Central Nervous System Nongerminomatous Germ Cell Tumor

Uterine Cervical Neoplasms

Brain Neoplasms, Cognitive Dysfunction

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Rectal Neoplasms

Wilms Tumor, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Oropharyngeal Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Carcinoma, Uterine Cervical Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Oropharyngeal Neoplasms

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Nasopharyngeal Neoplasms

Head and Neck Neoplasms

Prostatic Neoplasms

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Oropharyngeal Neoplasms

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Head and Neck Neoplasms

Rectal Neoplasms

Brain Neoplasms, Meningioma, Central Nervous System Neoplasms

Pancreatic Adenocarcinoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Prostatic Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Precancerous Conditions, Tongue Neoplasms, Papillomavirus Infections

Prostatic Neoplasms

Prostatic Neoplasms

Brain Neoplasms, Glioblastoma, Gliosarcoma

Head and Neck Neoplasms, Stomatitis

Glioblastoma, Gliosarcoma

Thyroid Carcinoma, Anaplastic

Clinical Trials

Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer

Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer

Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring

Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer

Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell Carcinoma

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

INRT-AIR: A Prospective Phase II Study of Involved Nodal Radiation Therapy

Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer

Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy

Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer

Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer

Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors

18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy

Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery

Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases

Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung Cancer

Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer

Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases

De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study

APA

Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer

De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca

Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck

Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin

CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer

Intensity-Modulated Radiation Therapy & Nivolumab for Recurrent or Second Primary Head & Neck Squamous Cell Cancer

Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck

P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC

PAINT

Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer

CORRECT

Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma

Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer

FACBC Outcomes for Post Prostatectomy

Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer

The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer

Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma

Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer